Target intelligence / Profile preview

Transmembrane protein 91 (TMEM91)

Target: TMEM91
Molecular classification: Transmembrane protein, Dispanin family

Overview

Transmembrane protein 91 is a protein coding gene belonging to the dispanin family, characterized by a common 2-transmembrane domain structure[1][7]. It is predicted to be active primarily in cellular membranes and may play a role in hematopoietic progenitor cell differentiation[2][3][7]. Although associated with breast cancer and osteogenesis imperfecta type V, there is currently no evidence it functions as a direct therapeutic target or has known drug interactions.

Other names: DSPC3FLJ27310IFITMD6SynDIG3Dispanin subfamily C member 3interferon induced transmembrane protein domain containing 6

Biological functions

Hematopoietic progenitor cell differentiationmembrane organization

Disease associations

Breast cancerOsteogenesis imperfecta type V

Beyond the preview

Go deeper on Transmembrane protein 91 (TMEM91).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Transmembrane protein 91 (TMEM91).

Explore the full profile